Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
73,172,323
-
Share change
-
+11,557,295
-
Total reported value
-
$2,253,923,874
-
Put/Call ratio
-
64%
-
Price per share
-
$30.80
-
Number of holders
-
280
-
Value change
-
+$356,190,213
-
Number of buys
-
180
-
Number of sells
-
79
Institutional Holders of GENMAB A/S - SPONSORED ADS (GMAB) as of Q4 2025
As of 31 Dec 2025,
GENMAB A/S - SPONSORED ADS (GMAB) was held by
280 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
73,172,323 shares.
The largest 10 holders included
Orbis Allan Gray Ltd, ALLIANCEBERNSTEIN L.P., Paradigm Biocapital Advisors LP, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, BlackRock, Inc., RENAISSANCE TECHNOLOGIES LLC, Harding Loevner LP, MORGAN STANLEY, FIRST TRUST ADVISORS LP, and GOLDMAN SACHS GROUP INC.
This page lists
282
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.